Background Hypertrophic cardiomyopathy is a common cause of non-ischaemic sudden cardiac death (SCD). Left ventricular ...
The optimal treatment of chronic coronary syndromes (CCS) represents to date a matter of debate as revascularisation has not ...
Background Limited empirical evidence informs driving restrictions after implantable cardioverter-defibrillator (ICD) ...
Background Cardiovascular disease (CVD) risk increases with age. Statins reduce cardiovascular risk but their effects are ...
Background Participation in regular exercise activities is recommended for patients with chronic heart failure. However, less ...
Correspondence to: Dr Siew Yen Ho, Paediatrics, Faculty of Medicine, National Heart & Lung Institute, Imperial College, Dovehouse Street, London SW3 6LY, UK; yen.ho{at}ic.ac.uk According to Walmsley, ...
Objective To determine the distribution and importance of various factors, especially the preventable ones, that contribute to cardiac decompensation and subsequent hospital admission for heart ...
Objective To determine the benefit of midodrine, an α agonist, on symptom frequency and haemodynamic responses during head up tilt in patients with neurocardiogenic syncope. Setting Cardiovascular ...
Correspondence to Dr Sam Dawkins, Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7JH, UK; sam{at}dawkins.org Severe secondary mitral regurgitation carries a poor prognosis ...
Correspondence to Professor Massimo Imazio, University Cardiology, AOU Città della Salute e della Scienza di Torino, Torino 10126, Italy; massimo_imazio{at}yahoo.it Colchicine is an ancient drug, ...
1 Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands 2 Health Psychology Section, Department of Health Sciences, University of Groningen ...
1 Imperial College, National Heart & Lung Institute, Royal Brompton Hospital, London, UK 2 Imperial College, National Heart & Lung Institute, Hammersmith Hospital, London, UK Correspondence to: Dr ...